DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ: DMII · FINANCIAL SERVICES · SHELL COMPANIES
$10.02
+0.10% today
Updated 2026-04-30
Market cap
$637.64M
P/E ratio
66.73
P/S ratio
—
EPS (TTM)
$0.15
Dividend yield
—
52W range
$10 – $10
Volume
0.1M
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | — | $0.00 |
| Revenue growth (YoY) | — | — |
| Cost of revenue | — | — |
| Gross profit | — | — |
| Gross margin | — | — |
| R&D | — | — |
| SG&A | — | $488385.00 |
| Operating income | $-151719.00 | $-1.30M |
| Operating margin | — | — |
| EBITDA | $-151719.00 | $-1.30M |
| EBITDA margin | — | — |
| EBIT | — | — |
| Interest expense | — | — |
| Income tax | — | — |
| Effective tax rate | 0.0% | 0.0% |
| Net income | $-151719.00 | $4.19M |
| Net income growth (YoY) | — | +2859.7% |
| Profit margin | — | — |